GlassScriptPhysician profile
Brian W Heaton
NPI 1245248236
$6,415.16
in general payments reported to CMS, 2019-2025
51 companies · $808 in 2025
The $808 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,076 · 2020: $297 · 2021: $799 · 2022: $1,238 · 2023: $483 · 2024: $715 · 2025: $808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,006.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,006.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,330.04 | 2019-2020 | |
| Boston Scientific Corporation | $1,088.02 | 2019-2025 | Advantage System, Rezum Generator, Lithovue |
| Astellas Pharma US INC | $449.25 | 2019-2025 | Xtandi |
| Procept Biorobotics Corporation | $405.03 | 2022-2025 | |
| Endo Pharmaceuticals INC. | $341.00 | 2019-2024 | Xiaflex, Aveed |
| 180 Medical, INC. | $312.86 | 2020-2025 | |
| Pfizer INC. | $275.04 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $158.74 | 2023-2025 | Orgovyx, Gemtesa |
| Travere Therapeutics, INC. | $153.44 | 2021-2022 | |
| Teleflex LLC | $146.11 | 2019-2024 | Urolift |
| Biocompatibles, INC. | $107.46 | 2019 | |
| Laborie Medical Technologies Corp. | $102.50 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Endo USA, INC. | $101.33 | 2024-2025 | Xiaflex, Aveed |
| Comsort, INC | $100.00 | 2019 | |
| Amgen INC. | $86.26 | 2019-2020 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Heaton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.